Spironolactone
Product Images NDC 70934-368

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70934-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 368 30 Rev A 02 20 1)

Label (70934 368 30 Rev A 02 20 1)
Spironolactone Tablets USP 50mg label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label indicates a bottle containing 30 tablets with storage instructions between 20°-25°C. The product is Rx only and protected from light. The label includes barcodes, NDC 70934-368-30, lot, expiration information, and peel-off prescription drug guide sections.*
FDA Label Image

Figure 1 (Spironolactone Figure 1)

Figure 1 (Spironolactone Figure 1)
A Kaplan-Meier plot showing probability over time in months for Spironolactone versus Placebo groups. The y-axis indicates probability from 0 to 1, and the x-axis represents months up to 48. Two lines depict survival probabilities, with Spironolactone group (n=822) showing higher probabilities compared to Placebo group (n=841). A log-rank p-value < 0.001 is indicated.*
FDA Label Image

Figure 2 (Spironolactone Figure 2)

Figure 2 (Spironolactone Figure 2)
A forest plot illustrating the hazard ratio (HR) and 95% confidence interval (CI) for various subgroups including age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium level, digoxin use, ACE inhibitor use, and beta blocker use. The plot compares Spironolactone versus placebo effectiveness in each subgroup, with sample sizes and percentages indicated.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure diagram of the active ingredient Spironolactone, showing its steroidal backbone with ketone and thioacetyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.